Immune Checkpoint Inhibitor-Related Bullous Pemphigoid with Negative Direct Immunofluorescence during Pembrolizumab Plus Lenvatinib Therapy: A Case Report
- DOI
- 10.1159/cde/abvag021
- Published
- 2026-10-09
- Container
- Case Reports in Dermatology
- Publisher
- S. Karger AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1159/cde/abvag021,
title = {Immune Checkpoint Inhibitor-Related Bullous Pemphigoid with Negative Direct Immunofluorescence during Pembrolizumab Plus Lenvatinib Therapy: A Case Report},
author = {Ayane Seko and Shimpei Nagai and Makiko Hino and Noriko Takatsuji and Terumi Shirane and Moito Iijima and Yoshihisa Hattori and Takashi Kurahashi},
year = {2026},
journal = {Case Reports in Dermatology},
doi = {10.1159/cde/abvag021},
url = {https://doi.org/10.1159/cde/abvag021}
}RIS
TY - JOUR TI - Immune Checkpoint Inhibitor-Related Bullous Pemphigoid with Negative Direct Immunofluorescence during Pembrolizumab Plus Lenvatinib Therapy: A Case Report AU - Ayane Seko AU - Shimpei Nagai AU - Makiko Hino AU - Noriko Takatsuji AU - Terumi Shirane AU - Moito Iijima AU - Yoshihisa Hattori AU - Takashi Kurahashi PY - 2026 JO - Case Reports in Dermatology DO - 10.1159/cde/abvag021 UR - https://doi.org/10.1159/cde/abvag021 ER -
APA
Seko, A., Nagai, S., Hino, M., Takatsuji, N., Shirane, T., Iijima, M., Hattori, Y., & Kurahashi, T. (2026). Immune Checkpoint Inhibitor-Related Bullous Pemphigoid with Negative Direct Immunofluorescence during Pembrolizumab Plus Lenvatinib Therapy: A Case Report. Case Reports in Dermatology. https://doi.org/10.1159/cde/abvag021
Source records
- crossref · retrieved 2026-11-08T19:58:42.132Z